Home › COPD › Pennsylvania › Philadelphia
Pag-aaral pangklinika para sa COPD sa Philadelphia, PA
26 pag-aaral para sa COPD ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Philadelphia (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Nagre-recruit
- Temple University - Temple Lung Center, Philadelphia
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Nagre-recruit
- Temple University Hospital, Philadelphia
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Nagre-recruitPhase 2
- DM Clinical Research - Philadelphia, Philadelphia
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Nagre-recruitPhase 2
- Research Site, Philadelphia
- Research Site, Philadelphia
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Nagre-recruitPhase 3
- Suburban Research Associates - Media- Site Number : 8400143, Media · 12 mi ang layo
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Nagre-recruitPhase 2/3
- Temple University Hospital, Philadelphia
- Temple Health Oaks, Phoenixville · 22 mi ang layo
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Nagre-recruit
- Temple University, Philadelphia
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Nagre-recruitPhase 3
- Temple University Hospital- Site Number : 8400059, Philadelphia
STRIVE Post-Market Registry Study
Nagre-recruitObservasyonal na pag-aaral
- Temple University, Philadelphia
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Nagre-recruitPhase 3
- Research Site, Horsham · 16 mi ang layo
- Research Site, Wilmington · 25 mi ang layo
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Nagre-recruitPhase 3
- GSK Investigational Site, Philadelphia
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Nagre-recruitPhase 3
- GSK Investigational Site, Wilmington · 25 mi ang layo
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Nagre-recruitPhase 3
- Research Site, Philadelphia
- Research Site, Philadelphia
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Nagre-recruit
- Penn Medicine, Philadelphia
- Temple University, Philadelphia
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Nagre-recruitPhase 2
- Temple University, Philadelphia
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Nagre-recruitPhase 3
- Research Site, Philadelphia
COPD Exacerbation Follow Up
Nagre-recruitObservasyonal na pag-aaral
- Thomas Jefferson University, Philadelphia
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Nagre-recruitPhase 3
- GSK Investigational Site, West Chester · 24 mi ang layo
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Nagre-recruit
- Temple University Hospital, Philadelphia
SPIROMICS Study of Early COPD Progression (SOURCE)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Temple University, Philadelphia
Feasibility of Semaglutide in Advanced Lung Disease
Nagre-recruitPhase 1/2
- University of Pennsylvania Perelman School of Medicine, Philadelphia
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
Nagre-recruitObservasyonal na pag-aaral
- Thomas Jefferson University, Philadelphia
Supporting Evidence-based Responses to Emotional Needs in Emphysema
Nagre-recruit
- University of Pennsylvania, Philadelphia
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Nagre-recruitObservasyonal na pag-aaral
- Temple University, Philadelphia
Temple Health Chest Initiative (THCI 2.0)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Temple University Of the Commonwealth System of Higher Education, Philadelphia
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Nagre-recruit
- Jeanes Hospital, Philadelphia
- Temple University, Philadelphia
Pag-aaral para sa COPD sa ibang lungsod
- Miami, FL20 pag-aaral
- Houston, TX18 pag-aaral
- Birmingham, AL17 pag-aaral
- Baltimore, MD16 pag-aaral
- Boston, MA15 pag-aaral
- Orlando, FL15 pag-aaral
- Chicago, IL15 pag-aaral
- Dallas, TX13 pag-aaral
- New York City, NY12 pag-aaral
- Pittsburgh, PA11 pag-aaral
- Winston-Salem, NC11 pag-aaral
- Hialeah, FL10 pag-aaral
Iba pang pag-aaral sa Philadelphia
- Kanser (lahat ng uri)57 pag-aaral
- Kanser sa Suso51 pag-aaral
- Non-Small Cell Lung Cancer49 pag-aaral
- Kanser sa Ovary47 pag-aaral
- Metastatic Cancer42 pag-aaral
- Colorectal Cancer41 pag-aaral
- Kanser sa Prostate41 pag-aaral
- Kanser sa Baga36 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Kanser ng Endometrium29 pag-aaral
- Kanser sa Pancreas26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.